HC Wainwright Estimates Senseonics’ Q1 Earnings (NYSE:SENS)

Senseonics Holdings, Inc. (NYSE:SENS) – Investment analysts at HC Wainwright lowered their Q1 2026 earnings estimates for shares of Senseonics in a research report issued on Tuesday, March 3rd. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of ($0.67) for the quarter, down from their previous estimate of ($0.49). HC Wainwright has a “Buy” rating and a $18.50 price target on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.14) per share. HC Wainwright also issued estimates for Senseonics’ Q2 2026 earnings at ($0.72) EPS, Q3 2026 earnings at ($0.78) EPS, Q4 2026 earnings at ($0.78) EPS, FY2026 earnings at ($2.95) EPS, FY2027 earnings at ($3.12) EPS, FY2028 earnings at ($2.72) EPS and FY2029 earnings at ($2.03) EPS.

A number of other equities analysts have also recently commented on SENS. Barclays reaffirmed an “overweight” rating and set a $31.00 price objective (up from $1.50) on shares of Senseonics in a research report on Wednesday, November 5th. Stifel Nicolaus set a $9.00 target price on shares of Senseonics in a report on Tuesday. Finally, TD Cowen reiterated a “buy” rating on shares of Senseonics in a research note on Thursday, January 8th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $22.70.

Senseonics Price Performance

NYSE:SENS opened at $6.87 on Thursday. Senseonics has a 12-month low of $5.25 and a 12-month high of $15.74. The firm has a market capitalization of $280.70 million, a price-to-earnings ratio of -52.85 and a beta of 0.99. The stock’s 50 day moving average price is $7.20 and its two-hundred day moving average price is $7.55. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Hedge Funds Weigh In On Senseonics

A number of hedge funds have recently added to or reduced their stakes in SENS. Maven Securities LTD bought a new stake in Senseonics during the second quarter worth about $129,000. Hood River Capital Management LLC bought a new position in Senseonics in the 2nd quarter valued at about $3,775,000. Sio Capital Management LLC acquired a new position in shares of Senseonics in the 2nd quarter valued at approximately $2,312,000. HBK Sorce Advisory LLC bought a new stake in shares of Senseonics during the 3rd quarter worth approximately $39,000. Finally, Keynote Financial Services LLC boosted its position in shares of Senseonics by 1,120.2% during the 2nd quarter. Keynote Financial Services LLC now owns 208,285 shares of the company’s stock worth $99,000 after acquiring an additional 191,215 shares in the last quarter. Institutional investors own 12.36% of the company’s stock.

Trending Headlines about Senseonics

Here are the key news stories impacting Senseonics this week:

• Positive Sentiment: Company guidance: Senseonics updated FY2026 revenue guidance to $58.0M–$62.0M, above the consensus revenue estimate of ~$50.3M — a near-term revenue beat that supports top-line growth expectations. Company / MarketBeat
• Neutral Sentiment: Street upside thesis: A recent Zacks write-up highlights a consensus price-target implying ~124.5% upside for SENS — a reminder that some analysts see significant long-term valuation upside, though such aggregated targets are not a guarantee. Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS)
• Neutral Sentiment: HC Wainwright still rates SENS a “Buy” with an $18.50 price target — the firm’s rating and target imply confidence in the longer-term story despite the cuts to earnings. HC Wainwright / MarketBeat
• Negative Sentiment: Major EPS downgrades: HC Wainwright significantly lowered EPS across Q1–Q4 2026 and pushed down FY2026–FY2029 (and issued an FY2030 estimate), e.g., FY2026 EPS cut to ($2.95) from ($2.27) and multi-year losses deepened — these revisions weaken near- and medium-term profitability expectations and are the primary driver of today’s share weakness. HC Wainwright cuts summary / MarketBeat

Senseonics Company Profile

Senseonics Holdings, Inc is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers.

The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe.